Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03517956 |
Title | Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors (ROCOCO) |
Acronym | ROCOCO |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Bayer |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ESP | DEU | BEL |